<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ISOFORMS: Genes with Clear Functional Differences Between Isoforms - AI Gene Review Projects</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-primary: #3498db;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1200px;
            margin: 0 auto;
        }

        .breadcrumb {
            margin-bottom: 1.5rem;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .breadcrumb a {
            color: var(--color-primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        h2 {
            font-size: 1.75rem;
            font-weight: 600;
            margin-top: 2rem;
            margin-bottom: 1rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        h3 {
            font-size: 1.25rem;
            font-weight: 600;
            margin-top: 1.5rem;
            margin-bottom: 0.75rem;
            color: #374151;
        }

        h4 {
            font-size: 1rem;
            font-weight: 600;
            margin-top: 1.25rem;
            margin-bottom: 0.5rem;
            color: #4b5563;
        }

        p {
            margin-bottom: 1rem;
        }

        a {
            color: var(--color-primary);
            text-decoration: none;
        }

        a:hover {
            text-decoration: underline;
        }

        /* Gene symbol links */
        .content a[href*="/genes/"] {
            background-color: #dbeafe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-weight: 500;
        }

        .content a[href*="/genes/"]:hover {
            background-color: #bfdbfe;
        }

        ul, ol {
            margin-bottom: 1rem;
            padding-left: 2rem;
        }

        li {
            margin-bottom: 0.25rem;
        }

        code {
            background: #f4f4f4;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-family: 'SFMono-Regular', Consolas, 'Liberation Mono', Menlo, monospace;
            font-size: 0.875em;
        }

        pre {
            background: #1f2937;
            color: #f9fafb;
            padding: 1rem;
            border-radius: 0.5rem;
            overflow-x: auto;
            margin-bottom: 1rem;
        }

        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }

        blockquote {
            border-left: 4px solid var(--color-primary);
            margin-left: 0;
            padding-left: 1.5rem;
            color: #4b5563;
            font-style: italic;
            margin-bottom: 1rem;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }

        th, td {
            border: 1px solid var(--border-color);
            padding: 0.75rem;
            text-align: left;
        }

        th {
            background-color: var(--bg-light);
            font-weight: 600;
            color: var(--text-muted);
            text-transform: uppercase;
            font-size: 0.75rem;
            letter-spacing: 0.05em;
        }

        tr:nth-child(even) {
            background-color: #f9fafb;
        }

        tr:hover {
            background-color: #f3f4f6;
        }

        /* Mermaid diagrams */
        .mermaid {
            text-align: center;
            margin: 2rem 0;
            background: white;
            padding: 1.5rem;
            border-radius: 0.5rem;
            border: 1px solid var(--border-color);
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        /* Warnings section */
        .warnings {
            background-color: #fef3c7;
            border: 1px solid #fde68a;
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 2rem;
        }

        .warnings h3 {
            color: #92400e;
            margin-top: 0;
            margin-bottom: 0.5rem;
            font-size: 1rem;
        }

        .warnings ul {
            margin-bottom: 0;
            color: #78350f;
        }

        /* Task lists (checkboxes) */
        li input[type="checkbox"] {
            margin-right: 0.5rem;
        }

        /* Status badges */
        .badge {
            display: inline-block;
            padding: 0.25rem 0.625rem;
            border-radius: 9999px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
        }

        .badge-success {
            background-color: #d1fae5;
            color: #065f46;
        }

        .badge-warning {
            background-color: #fef3c7;
            color: #92400e;
        }

        .badge-info {
            background-color: #dbeafe;
            color: #1e40af;
        }

        /* Content wrapper */
        .content {
            margin-bottom: 2rem;
        }

        /* Footer */
        footer {
            margin-top: 3rem;
            padding-top: 1.5rem;
            border-top: 1px solid var(--border-color);
            color: var(--text-muted);
            font-size: 0.875rem;
            text-align: center;
        }

        footer small {
            display: block;
        }
    </style>
    <!-- Mermaid.js for diagram rendering -->
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <nav class="breadcrumb">
        <a href="../index.html">Home</a> &raquo;
        <a href="index.html">Projects</a> &raquo;
        ISOFORMS: Genes with Clear Functional Differences Between Isoforms
    </nav>

    <header class="header">
        <h1>ISOFORMS: Genes with Clear Functional Differences Between Isoforms</h1>
        
    </header>

    

    <div class="content">
        <h1 id="isoforms-genes-with-clear-functional-differences-between-isoforms">ISOFORMS: Genes with Clear Functional Differences Between Isoforms</h1>
<h2 id="overview">Overview</h2>
<p>This project explores genes where alternative splicing produces isoforms with <strong>demonstrably different biological functions</strong>. These cases are particularly important for GO annotation because:</p>
<ol>
<li><strong>Standard annotation often conflates isoform functions</strong> - a single gene gets annotated with functions that may only apply to specific isoforms</li>
<li><strong>Isoform-specific annotations are rare in GO</strong> - most annotations are made at the gene level</li>
<li><strong>Understanding isoform biology is critical</strong> for precision medicine and accurate functional characterization</li>
</ol>
<h2 id="selection-criteria">Selection Criteria</h2>
<p>Genes selected for this project should have:<br />
- Well-characterized alternative splicing events<br />
- <strong>Clear functional differences</strong> between isoforms (not just expression pattern differences)<br />
- Preferably <strong>opposing or divergent functions</strong> (e.g., pro-apoptotic vs anti-apoptotic)<br />
- Strong experimental evidence for isoform-specific activities</p>
<h2 id="priority-genes">Priority Genes</h2>
<h3 id="tier-1-classic-paradigms-start-here">Tier 1: Classic Paradigms (Start Here)</h3>
<ul>
<li>[ ] <strong><a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a></strong> (human) - Agrin: neuronal Z+ isoforms cluster AChRs at NMJ; muscle Z- isoforms do not</li>
<li>[ ] <strong><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a></strong> (human) - Bcl-x: Bcl-xL is anti-apoptotic; Bcl-xS is pro-apoptotic (antagonistic!)</li>
<li>[ ] <strong><a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a></strong> (human) - VEGF: isoforms differ in heparin binding, diffusibility, and vascular patterning</li>
<li>[ ] <strong><a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a></strong> (human) - CD95: membrane isoform triggers apoptosis; soluble isoform inhibits it</li>
<li>[ ] <strong><a href="../../genes/human/CASP9/CASP9-ai-review.html">CASP9</a></strong> (human) - Caspase-9: constitutive form induces apoptosis; short isoform inhibits it</li>
</ul>
<h3 id="tier-2-developmentaltissue-specific">Tier 2: Developmental/Tissue-Specific</h3>
<ul>
<li>[ ] <strong><a href="../../genes/human/FN1/FN1-ai-review.html">FN1</a></strong> (human) - Fibronectin: EDA/EDB isoforms are embryonic/wound-healing specific</li>
<li>[ ] <strong><a href="../../genes/human/TPM1/TPM1-ai-review.html">TPM1</a></strong> (human) - Tropomyosin: striated muscle vs smooth muscle vs non-muscle isoforms</li>
<li>[ ] <strong><a href="../../genes/human/TPM3/TPM3-ai-review.html">TPM3</a></strong> (human) - Tropomyosin 3: slow muscle fiber specific isoform</li>
<li>[ ] <strong><a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a></strong> (human) - Note: human <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> lacks the extreme diversity of Drosophila <a href="../../genes/DROME/Dscam1/Dscam1-ai-review.html">Dscam1</a></li>
</ul>
<h3 id="tier-3-additional-cases-to-explore">Tier 3: Additional Cases to Explore</h3>
<ul>
<li>[ ] <strong><a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a></strong> (human) - FGF receptor 2: IIIb vs IIIc isoforms have different ligand specificities</li>
<li>[ ] <strong><a href="../../genes/human/PKM/PKM-ai-review.html">PKM</a></strong> (human) - Pyruvate kinase: PKM1 (adult muscle) vs PKM2 (embryonic, cancer)</li>
<li>[ ] <strong>PTBP1/2</strong> (human) - Master splicing regulators that control many isoform switches</li>
<li>[ ] <strong>RON/MST1R</strong> (human) - Proto-oncogene with motility-promoting splice variant in cancer</li>
<li>[ ] <strong><a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a></strong> (human) - <a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a>α vs <a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a>β have distinct transcriptional activities</li>
</ul>
<h3 id="special-cases-polyproteins-post-translational-cleavage">Special Cases: Polyproteins (Post-Translational Cleavage)</h3>
<p>These are NOT alternative splicing but share the annotation challenge of multiple functional products from one gene:</p>
<ul>
<li>[x] <strong><a href="../../genes/human/POMC/POMC-ai-review.html">POMC</a></strong> (human) - Pro-opiomelanocortin: cleaved into ACTH, alpha-MSH, beta-endorphin with ANTAGONISTIC functions (anorexigenic vs orexigenic)</li>
<li>[x] <strong><a href="../../genes/mouse/App/App-ai-review.html">App</a></strong> (mouse) - Amyloid precursor protein: BOTH splicing (APP695 vs APP751/770 KPI) AND cleavage (sAPPalpha NEUROPROTECTIVE vs Abeta NEUROTOXIC) - most complex case</li>
<li>[x] <strong><a href="../../genes/human/APP/APP-ai-review.html">APP</a></strong> (human) - Human ortholog, directly relevant to Alzheimer's disease with familial mutations</li>
</ul>
<h2 id="background-key-concepts">Background: Key Concepts</h2>
<h3 id="types-of-functional-differences">Types of Functional Differences</h3>
<ol>
<li><strong>Antagonistic functions</strong> - Bcl-xL vs Bcl-xS, membrane vs soluble Fas</li>
<li><strong>Tissue-specific activity</strong> - Agrin Z+ (neuronal) vs Z- (muscle)</li>
<li><strong>Localization differences</strong> - VEGF isoforms (diffusible vs matrix-bound)</li>
<li><strong>Ligand specificity</strong> - <a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a> IIIb vs IIIc</li>
<li><strong>Regulatory vs constitutive</strong> - PKM1 vs PKM2</li>
</ol>
<h3 id="drosophila-vs-human-dscam-case-study">Drosophila vs Human: <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> Case Study</h3>
<p><em>Drosophila</em> <a href="../../genes/DROME/Dscam1/Dscam1-ai-review.html">Dscam1</a> is a spectacular example of isoform diversity - 38,016 potential isoforms from mutually exclusive splicing of 4 exon clusters. Each neuron expresses a unique repertoire enabling self-avoidance. <strong>However, human <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> does not have this diversity</strong> - vertebrates achieve similar neuronal specificity through clustered protocadherins instead.</p>
<h3 id="go-annotation-challenges">GO Annotation Challenges</h3>
<p>Current GO annotation practice typically:<br />
- Annotates at the gene product level (canonical isoform)<br />
- Uses PRO ontology IDs for isoform-specific annotations (but rarely)<br />
- May conflate functions that are isoform-specific</p>
<p>This project should:<br />
1. Document isoform-specific functions clearly<br />
2. Recommend which functions apply to which isoforms<br />
3. Suggest GO annotation improvements</p>
<h3 id="isoform-tracking-in-this-project">Isoform Tracking in This Project</h3>
<p><strong>As of 2026-01-18</strong>, the data model and ETL have been extended to track isoform-specific annotations:</p>
<ul>
<li>The <code>ExistingAnnotation</code> class now has an optional <code>isoform</code> field</li>
<li>When GOA annotations use UniProt isoform IDs (e.g., <code>P19544-1</code>), the isoform is automatically extracted</li>
<li>The field stores the full UniProt isoform ID when present</li>
<li>Canonical annotations (no isoform suffix) have this field omitted</li>
</ul>
<p><strong>Important caveat</strong>: Just because an annotation was made on a specific isoform doesn't necessarily mean the function is isoform-specific. Researchers may have used a particular isoform for convenience. The <code>isoform</code> field indicates <em>what was tested</em>, not necessarily <em>what is unique to that isoform</em>.</p>
<h2 id="references">References</h2>
<p>Key reviews and resources:<br />
- <a href="https://en.wikipedia.org/wiki/Alternative_splicing">Alternative splicing - Wikipedia</a><br />
- <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8951537/">Alternative Splicing and Isoforms: From Mechanisms to Diseases (PMC)</a><br />
- <a href="https://www.nature.com/articles/s41419-019-1407-6">BCL-2 family isoforms in apoptosis and cancer (Nature Cell Death Dis)</a><br />
- <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10139058/">Neural Isoforms of Agrin (PMC)</a><br />
- <a href="https://www.nature.com/articles/s41392-025-02249-0">VEGF isoforms and angiogenesis (Nature)</a></p>
<hr />
<h1 id="status">STATUS</h1>
<h2 id="progress-tracking">Progress Tracking</h2>
<h3 id="tier-1-genes">Tier 1 Genes</h3>
<ul>
<li>[x] <a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> - <strong>COMPLETE</strong> - Excellent paradigm case with detailed isoform discussion</li>
<li>[x] <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> - <strong>COMPLETE</strong> - +KTS vs -KTS isoforms, NOT annotation reviewed</li>
<li>[x] <a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a> - <strong>COMPLETE</strong> - 110 annotations | 8 OVER_ANNOTATED (pro/anti-apoptotic conflation)</li>
<li>[x] <a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a> - <strong>COMPLETE</strong> - 96 annotations | membrane vs soluble antagonism documented</li>
<li>[x] <a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a> - <strong>COMPLETE</strong> - 268 annotations | 21 OVER_ANNOTATED (anti-angiogenic VEGF165B)</li>
<li>[x] <a href="../../genes/human/CASP9/CASP9-ai-review.html">CASP9</a> - <strong>COMPLETE</strong> - 114 annotations | dominant-negative isoform 2 documented</li>
</ul>
<h3 id="tier-2-genes">Tier 2 Genes</h3>
<ul>
<li>[x] <a href="../../genes/human/FN1/FN1-ai-review.html">FN1</a> - <strong>COMPLETE</strong> - 193 annotations | EDA/EDB domain developmental splicing</li>
<li>[x] <a href="../../genes/human/TPM1/TPM1-ai-review.html">TPM1</a> - <strong>COMPLETE</strong> - 55 annotations | 9 OVER_ANNOTATED (muscle vs cytoskeletal isoforms)</li>
<li>[x] <a href="../../genes/human/TPM3/TPM3-ai-review.html">TPM3</a> - <strong>COMPLETE</strong> - 39 annotations | 16 OVER_ANNOTATED (slow muscle vs TM30nm cytoskeletal)</li>
<li>[x] <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> - <strong>COMPLETE</strong> - 50 annotations | 4 OVER_ANNOTATED (human has only 2 isoforms, not 38,016!)</li>
</ul>
<h3 id="tier-3-genes">Tier 3 Genes</h3>
<ul>
<li>[x] <a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a> - <strong>COMPLETE</strong> - 229 annotations | 16 OVER_ANNOTATED (IIIb vs IIIc ligand specificity)</li>
<li>[x] <a href="../../genes/human/PKM/PKM-ai-review.html">PKM</a> - <strong>COMPLETE</strong> - 79 annotations | 6 OVER_ANNOTATED (M1 vs <a href="../../genes/9INFA/M2/M2-ai-review.html">M2</a> Warburg effect)</li>
<li>[ ] PTBP1/2 - Not started (splicing regulators, different project focus)</li>
<li>[ ] RON/MST1R - Not started</li>
<li>[x] <a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a> - <strong>COMPLETE</strong> - 456 annotations | alpha vs beta dominant-negative documented</li>
</ul>
<h2 id="summary-stats">Summary Stats</h2>
<ul>
<li><strong>Total genes</strong>: 15</li>
<li><strong>Completed</strong>: 13 (Tier 1 + Tier 2 + 3 Tier 3)</li>
<li><strong>In progress</strong>: 0</li>
<li><strong>Tier 1 genes</strong>: 6/6 COMPLETE</li>
<li><strong>Tier 2 genes</strong>: 4/4 COMPLETE</li>
<li><strong>Tier 3 genes</strong>: 3/5 COMPLETE</li>
<li><strong>Total annotations reviewed</strong>: 1689 across completed genes</li>
</ul>
<hr />
<h1 id="notes">NOTES</h1>
<h2 id="2026-01-19">2026-01-19</h2>
<p><strong>New Data Model: <code>functional_isoforms</code></strong></p>
<p>Added a new curator-defined field to the schema for tracking functionally distinct gene products. Unlike <code>alternative_products</code> (ETL-seeded from UniProt), this is purely curated:</p>
<div class="codehilite"><pre><span></span><code><span class="nt">FunctionalIsoformTypeEnum</span><span class="p">:</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">SPLICE_VARIANT</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">Single splice isoform</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">SPLICE_CLASS</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">Group of related isoforms (e.g., [WT1](../../genes/human/WT1/WT1-ai-review.html) +KTS vs -KTS)</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">CLEAVAGE_PRODUCT</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">Post-translational proteolysis (e.g., [POMC](../../genes/human/POMC/POMC-ai-review.html) peptides)</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">MODIFICATION_STATE</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">PTM-dependent states</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">CONFORMATIONAL_STATE</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">Distinct functional conformations</span>

<span class="nt">FunctionalIsoformMappingTypeEnum</span><span class="p">:</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">UNIPROT_ISOFORM</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">e.g., P19544-1</span>
<span class="w">  </span><span class="p p-Indicator">-</span><span class="w"> </span><span class="nt">UNIPROT_CHAIN</span><span class="p">:</span><span class="w"> </span><span class="l l-Scalar l-Scalar-Plain">e.g., PRO_0000024969 (UniProt [FT](../../genes/ARATH/FT/FT-ai-review.html) PEPTIDE)</span>
</code></pre></div>

<p><strong>IMPORTANT</strong>: UniProt chain/peptide IDs (PRO_NNNNNNN) have NOTHING to do with the PRO ontology (PR:NNNNNNN namespace). Different systems!</p>
<hr />
<p><strong><a href="../../genes/human/POMC/POMC-ai-review.html">POMC</a> Review Complete (Polyprotein Paradigm):</strong></p>
<p><a href="../../genes/human/POMC/POMC-ai-review.html">POMC</a> is fundamentally different from alternative splicing - it's a <strong>polyprotein</strong> cleaved into multiple bioactive peptides:</p>
<table>
<thead>
<tr>
<th>Peptide</th>
<th>UniProt Chain</th>
<th>Function</th>
<th>Effect on Appetite</th>
</tr>
</thead>
<tbody>
<tr>
<td>ACTH</td>
<td>PRO_0000024969</td>
<td>Cortisol release (HPA axis)</td>
<td>-</td>
</tr>
<tr>
<td>Alpha-MSH</td>
<td>PRO_0000024970</td>
<td>MC4R binding, pigmentation</td>
<td>ANOREXIGENIC</td>
</tr>
<tr>
<td>Beta-endorphin</td>
<td>PRO_0000024975</td>
<td>Opioid signaling</td>
<td>OREXIGENIC</td>
</tr>
<tr>
<td>Beta-MSH</td>
<td>PRO_0000024974</td>
<td>MC1R binding, pigmentation</td>
<td>-</td>
</tr>
<tr>
<td>Gamma-MSH</td>
<td>PRO_0000024967</td>
<td>Sodium regulation</td>
<td>-</td>
</tr>
</tbody>
</table>
<p><strong>Key insight</strong>: Alpha-MSH and beta-endorphin are produced in the SAME hypothalamic neurons but have ANTAGONISTIC effects on appetite. This is a paradigm case of why gene-level annotation is insufficient.</p>
<p>55 annotations reviewed: 42 ACCEPT, 4 NON_CORE, 5 OVER_ANNOTATED, 1 MODIFY, 3 REMOVE</p>
<hr />
<p><strong><a href="../../genes/mouse/App/App-ai-review.html">App</a> (Mouse) Review Complete - Most Complex Case Yet:</strong></p>
<p><a href="../../genes/mouse/App/App-ai-review.html">App</a> demonstrates BOTH alternative splicing AND proteolytic cleavage:</p>
<table>
<thead>
<tr>
<th>Type</th>
<th>Variant</th>
<th>Function</th>
</tr>
</thead>
<tbody>
<tr>
<td>SPLICE</td>
<td>APP695</td>
<td>Neuronal, no KPI domain</td>
</tr>
<tr>
<td>SPLICE</td>
<td>APP751/770</td>
<td>Peripheral, has KPI (protease inhibitor)</td>
</tr>
<tr>
<td>CLEAVAGE</td>
<td>sAPPalpha</td>
<td><strong>NEUROPROTECTIVE</strong> (non-amyloidogenic)</td>
</tr>
<tr>
<td>CLEAVAGE</td>
<td>Abeta42</td>
<td><strong>NEUROTOXIC</strong> (Alzheimer's)</td>
</tr>
<tr>
<td>CLEAVAGE</td>
<td>AICD</td>
<td>Nuclear signaling (controversial)</td>
</tr>
</tbody>
</table>
<p><strong>Critical insight</strong>: The same gene produces both NEUROPROTECTIVE (sAPPalpha) and NEUROTOXIC (Abeta) products depending on whether alpha-secretase or beta-secretase cleaves first. This is a paradigm for how proteolytic processing balance determines cell fate.</p>
<p>342 annotations reviewed: 267 ACCEPT, 62 OVER_ANNOTATED (Abeta-specific), 8 NON_CORE, 1 MODIFY, 1 REMOVE</p>
<hr />
<p><strong>Template Updates Complete:</strong></p>
<p>The Jinja2 template (<code>gene_review.html.j2</code>) has been fully updated to support isoform tracking:</p>
<ol>
<li>
<p><strong>Alternative Products section</strong> - Renders isoform cards showing id, name, sequence_note, and description for each isoform (implemented earlier)</p>
</li>
<li>
<p><strong>Isoform badge on annotations</strong> - NEW: Annotations with <code>isoform</code> field now display a blue badge linking to the UniProt isoform (e.g., P19544-1)</p>
</li>
<li>
<p><strong>NOT badge on annotations</strong> - NEW: Negated annotations (<code>negated: true</code>) now display a red "NOT" badge</p>
</li>
</ol>
<p><strong>Tested with:</strong><br />
- <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a>: Verified isoform-specific annotations (P19544-1) and NOT annotations display correctly<br />
- <a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a>: Verified Alternative Products section renders Bcl-xL, Bcl-xS, and Q07817-3 isoforms</p>
<hr />
<p><strong>Tier 3 Annotation Review Progress:</strong></p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Total</th>
<th>ACCEPT</th>
<th>NON_CORE</th>
<th>OVER_ANNOTATED</th>
<th>MODIFY</th>
<th>Key Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a></td>
<td>229</td>
<td>160</td>
<td>45</td>
<td>16</td>
<td>6</td>
<td>IIIb vs IIIc ligand specificity</td>
</tr>
<tr>
<td><a href="../../genes/human/PKM/PKM-ai-review.html">PKM</a></td>
<td>79</td>
<td>31</td>
<td>35</td>
<td>6</td>
<td>7</td>
<td>M1 vs <a href="../../genes/9INFA/M2/M2-ai-review.html">M2</a> Warburg effect</td>
</tr>
<tr>
<td><a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a></td>
<td>456</td>
<td>364</td>
<td>26</td>
<td>0</td>
<td>0</td>
<td>Alpha vs beta dominant-negative</td>
</tr>
</tbody>
</table>
<p><strong>Key Tier 3 Findings:</strong></p>
<ol>
<li>
<p><strong><a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a></strong>: Classic epithelial/mesenchymal isoform switch. FGFR2IIIb (P21802-3) is epithelial-specific and binds FGF7/KGF and FGF10. FGFR2IIIc (P21802-1) is mesenchymal-specific and binds FGF2/FGF4. This enables paracrine signaling between tissue compartments. 16 annotations marked as potentially isoform-specific or over-annotated.</p>
</li>
<li>
<p><strong><a href="../../genes/human/PKM/PKM-ai-review.html">PKM</a></strong>: The M1/<a href="../../genes/9INFA/M2/M2-ai-review.html">M2</a> switch is fundamental to the Warburg effect. PKM1 (P14618-2) is constitutively active in adult differentiated tissues. PKM2 (P14618-1) has low activity and is allosterically regulated - this diverts glycolytic intermediates to biosynthesis in proliferating/cancer cells. PKM2 also has PKM1-absent functions: protein kinase activity, nuclear translocation, and transcription coactivation. 6 annotations identified as PKM2-specific.</p>
</li>
<li>
<p><strong><a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a></strong>: Alpha (P40763-1) has full transactivation domain; beta (P40763-2) lacks TAD and can act as dominant-negative. Already reviewed - 456 annotations processed with isoform biology documented.</p>
</li>
</ol>
<p><strong>Tier 3 Progress: 3/5 genes complete (<a href="../../genes/human/FGFR2/FGFR2-ai-review.html">FGFR2</a>, <a href="../../genes/human/PKM/PKM-ai-review.html">PKM</a>, <a href="../../genes/human/STAT3/STAT3-ai-review.html">STAT3</a>)</strong></p>
<p>Remaining: PTBP1/2 (splicing regulators - different focus), RON/MST1R</p>
<hr />
<p><strong>Tier 2 Annotation Review Completed:</strong></p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Total</th>
<th>ACCEPT</th>
<th>NON_CORE</th>
<th>OVER_ANNOTATED</th>
<th>Key Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="../../genes/human/FN1/FN1-ai-review.html">FN1</a></td>
<td>193</td>
<td>62</td>
<td>39</td>
<td>0</td>
<td>EDA/EDB developmental splicing</td>
</tr>
<tr>
<td><a href="../../genes/human/TPM1/TPM1-ai-review.html">TPM1</a></td>
<td>55</td>
<td>34</td>
<td>12</td>
<td>9</td>
<td>Muscle vs cytoskeletal isoforms</td>
</tr>
<tr>
<td><a href="../../genes/human/TPM3/TPM3-ai-review.html">TPM3</a></td>
<td>39</td>
<td>19</td>
<td>4</td>
<td>16</td>
<td>Slow muscle vs TM30nm cytoskeletal</td>
</tr>
<tr>
<td><a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a></td>
<td>50</td>
<td>42</td>
<td>3</td>
<td>4</td>
<td>Only 2 isoforms (not like Drosophila!)</td>
</tr>
</tbody>
</table>
<p><strong>Key Tier 2 Findings:</strong></p>
<ol>
<li>
<p><strong><a href="../../genes/human/FN1/FN1-ai-review.html">FN1</a></strong>: 17 isoforms with EDA/EDB domain variation. Plasma FN (hepatocyte) vs cellular FN (fibroblast). EDA/EDB+ isoforms are oncofetal antigens used in cancer imaging.</p>
</li>
<li>
<p><strong><a href="../../genes/human/TPM1/TPM1-ai-review.html">TPM1</a>/<a href="../../genes/human/TPM3/TPM3-ai-review.html">TPM3</a></strong>: Tissue-specific tropomyosin isoforms - skeletal muscle, smooth muscle, cardiac, and cytoskeletal variants. Annotations for "muscle contraction" often apply only to muscle isoforms. <a href="../../genes/human/TPM3/TPM3-ai-review.html">TPM3</a> had highest over-annotation rate (16/39).</p>
</li>
<li>
<p><strong><a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a></strong>: CRITICAL CAVEAT - Human <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> has only 2 isoforms, NOT the 38,016 of Drosophila <a href="../../genes/DROME/Dscam1/Dscam1-ai-review.html">Dscam1</a>! Vertebrates use protocadherins instead. Some IBA annotations may be inappropriately extrapolated from fly.</p>
</li>
</ol>
<p><strong>Tier 1 + Tier 2 now complete: 925 annotations reviewed across 10 genes</strong></p>
<hr />
<p><strong>Major Annotation Review Completed:</strong></p>
<p>Completed full annotation reviews for <a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a>, <a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a>, <a href="../../genes/human/CASP9/CASP9-ai-review.html">CASP9</a>, and significant progress on <a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a>:</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Total</th>
<th>ACCEPT</th>
<th>NON_CORE</th>
<th>OVER_ANNOTATED</th>
<th>MODIFY</th>
<th>Key Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a></td>
<td>110</td>
<td>41</td>
<td>9</td>
<td>8</td>
<td>50</td>
<td>Pro/anti-apoptotic conflation</td>
</tr>
<tr>
<td><a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a></td>
<td>96</td>
<td>62</td>
<td>10</td>
<td>0</td>
<td>23</td>
<td>Membrane vs soluble antagonism</td>
</tr>
<tr>
<td><a href="../../genes/human/CASP9/CASP9-ai-review.html">CASP9</a></td>
<td>114</td>
<td>70</td>
<td>41</td>
<td>0</td>
<td>2</td>
<td>Dominant-negative isoform</td>
</tr>
<tr>
<td><a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a></td>
<td>268</td>
<td>150</td>
<td>59</td>
<td>21</td>
<td>0</td>
<td>Anti-angiogenic VEGF165B</td>
</tr>
</tbody>
</table>
<p><strong>All Tier 1 genes now COMPLETE!</strong></p>
<p><strong>Key Isoform Biology Documented:</strong></p>
<ol>
<li>
<p><strong><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a></strong>: Bcl-xL (anti-apoptotic) vs Bcl-xS (pro-apoptotic) - classic antagonism. 8 annotations marked OVER_ANNOTATED where pro-apoptotic function was incorrectly applied to the whole gene (Bcl-xL is anti-apoptotic).</p>
</li>
<li>
<p><strong><a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a></strong>: Membrane isoform 1 triggers apoptosis via DISC; soluble isoforms 2-6 BLOCK apoptosis as decoy receptors. GOA has BOTH <a href="http://amigo.geneontology.org/amigo/term/GO:0043065">GO:0043065</a> (positive) AND <a href="http://amigo.geneontology.org/amigo/term/GO:0043066">GO:0043066</a> (negative) apoptosis regulation.</p>
</li>
<li>
<p><strong><a href="../../genes/human/CASP9/CASP9-ai-review.html">CASP9</a></strong>: Caspase-9L (isoform 1) induces apoptosis; Caspase-9S (isoform 2) is dominant-negative inhibitor competing for Apaf-1 binding. The 9L/9S ratio determines apoptotic sensitivity.</p>
</li>
<li>
<p><strong><a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a></strong>: 17 isoforms including VEGF165B (P15692-8) which is ANTI-angiogenic while canonical isoforms are pro-angiogenic. 11 annotations marked OVER_ANNOTATED.</p>
</li>
</ol>
<p><strong>Isoform Conflation Pattern Confirmed:</strong></p>
<p>All four genes show the same pattern: GO annotations conflate opposing functions of different splice isoforms. This is exactly the problem the ISOFORMS project was designed to identify.</p>
<hr />
<h2 id="2026-01-18">2026-01-18</h2>
<p><strong><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a> Review Started:</strong></p>
<p><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a> is a PARADIGM case of antagonistic isoform functions:</p>
<ol>
<li><strong>Bcl-xL (Q07817-1, 233 AA)</strong>: Anti-apoptotic, contains BH1-4 domains</li>
<li><strong>Bcl-xS (Q07817-2, 166 AA)</strong>: Pro-apoptotic, lacks BH1/BH2 domains</li>
<li><strong>Bcl-xS</strong> can heterodimerize with Bcl-xL to inhibit its function</li>
</ol>
<p><strong>Isoform Conflation Identified:</strong><br />
- <a href="http://amigo.geneontology.org/amigo/term/GO:0043065">GO:0043065</a> "positive regulation of apoptotic process" (IBA) - MARKED AS OVER_ANNOTATED<br />
  - This annotation likely reflects Bcl-xS function but is applied to the whole gene<br />
  - The canonical isoform Bcl-xL is ANTI-apoptotic<br />
  - IBA evidence doesn't distinguish isoforms</p>
<ul>
<li><a href="http://amigo.geneontology.org/amigo/term/GO:0043066">GO:0043066</a> "negative regulation of apoptotic process" (IDA x2) - ACCEPTED</li>
<li>Core function of Bcl-xL, supported by PMID:9388232 and PMID:7650367</li>
</ul>
<p><strong>Key Finding:</strong> The GOA has BOTH pro-apoptotic and anti-apoptotic annotations because it conflates the antagonistic isoforms. This is exactly the type of annotation error we aimed to identify in this project.</p>
<hr />
<p><strong><a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> NOT Annotation Reviewed:</strong></p>
<p><a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> has isoform-specific annotations in GOA (P19544-1 = +KTS isoform). We reviewed and fixed:</p>
<ol>
<li><strong>NOT annotation for <a href="http://amigo.geneontology.org/amigo/term/GO:0045893">GO:0045893</a></strong> (positive regulation of DNA-templated transcription)</li>
<li>The +KTS isoform (P19544-1) does NOT activate transcription</li>
<li>The -KTS isoform DOES activate transcription (e.g., SRY promoter)</li>
<li>PMID:9815658 clearly shows this isoform-specific difference</li>
<li>
<p>Action: ACCEPT - this is a well-documented paradigm case</p>
</li>
<li>
<p><strong>Fixed duplicate annotation bug</strong>: There was an incorrect positive annotation claiming +KTS activates transcription - removed this as the GOA correctly has it as a NOT annotation.</p>
</li>
<li>
<p><strong>Key biology</strong>: The 3-amino acid KTS insertion between zinc fingers 3 and 4 changes <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a>'s DNA binding properties. +KTS localizes to nuclear speckles and associates with splicing factors; -KTS acts as a transcription factor.</p>
</li>
</ol>
<p><strong>Added <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> to tracking</strong> - While not originally in the project gene list, <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> is an excellent example of isoform-specific function with both:<br />
- Positive annotations specific to -KTS isoforms<br />
- NOT annotations specific to +KTS isoforms</p>
<hr />
<p><strong><a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> Review Complete:</strong></p>
<p>The <a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> gene review was already complete (105 annotations reviewed). <a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> serves as an excellent paradigm case for this project because the review captures:</p>
<ol>
<li><strong>Two types of isoform variation:</strong></li>
<li><strong>N-terminal diversity</strong>: LN-agrin (isoform 1, secreted) vs SN-agrin (isoform 2, transmembrane)</li>
<li>
<p><strong>C-terminal splice variants</strong>: z+ (neural, contain z8 insert) vs z0 (muscle, no insert)</p>
</li>
<li>
<p><strong>Functionally distinct activities:</strong></p>
</li>
<li>Neural z+ isoforms: Active at NMJ, induce AChR clustering via LRP4-MuSK</li>
<li>
<p>Muscle z0 isoforms: Structural roles in basement membranes, no NMJ clustering activity</p>
</li>
<li>
<p><strong>The review correctly distinguishes:</strong></p>
</li>
<li>"neuromuscular junction development" as a CORE function (z+ specific)</li>
<li>"basement membrane" as a CORE localization (both isoforms but LN-agrin dominant)</li>
<li>"nervous system development" as NON_CORE (too broad)</li>
</ol>
<p><strong>Key insight</strong>: While the GOA file doesn't contain explicit isoform-specific annotations (no <code>O00468-1</code> or <code>O00468-2</code>), the review narrative correctly captures isoform-specific biology in the summaries and reasons.</p>
<hr />
<p><strong>Extended data model for isoform tracking:</strong><br />
- Added optional <code>isoform</code> field to <code>ExistingAnnotation</code> in <code>gene_review.yaml</code> schema<br />
- Updated <code>GOAAnnotation</code> dataclass in <code>goa_validator.py</code> to extract isoform from gene product ID<br />
- UniProt isoform IDs (e.g., <code>P19544-1</code>) are now automatically detected and stored<br />
- Added comprehensive tests for isoform extraction and seeding<br />
- All 29 GOA validator tests pass</p>
<p><strong>Human genes with isoform-specific annotations identified in existing GOA files:</strong><br />
- <a href="../../genes/human/BCL2L12/BCL2L12-ai-review.html">BCL2L12</a> (Q9HB09-1)<br />
- <a href="../../genes/human/DAB2IP/DAB2IP-ai-review.html">DAB2IP</a> (Q5VWQ8-2)<br />
- <a href="../../genes/human/NFS1/NFS1-ai-review.html">NFS1</a> (Q9Y697-2)<br />
- <a href="../../genes/human/PTEN/PTEN-ai-review.html">PTEN</a> (P60484-2)<br />
- <a href="../../genes/human/SGCA/SGCA-ai-review.html">SGCA</a> (Q16586-2)<br />
- <a href="../../genes/human/WT1/WT1-ai-review.html">WT1</a> (P19544-1)</p>
<h2 id="2026-01-16">2026-01-16</h2>
<p>Initial project creation. Research conducted on classic isoform cases:</p>
<p><strong>Key findings from literature search:</strong></p>
<ol>
<li><strong><a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> (Agrin)</strong> - Excellent paradigm case</li>
<li>Z+ isoforms (neuronal): contain 8-19 AA inserts, potent AChR clustering activity</li>
<li>Z- isoforms (muscle): lack inserts, no clustering activity</li>
<li>Regulated by NOVA1/2 and PTBP1 during neuronal differentiation</li>
<li>
<p>Clinical relevance: mis-splicing in SMA</p>
</li>
<li>
<p><strong><a href="../../genes/human/BCL2L1/BCL2L1-ai-review.html">BCL2L1</a> (Bcl-x)</strong> - Classic antagonistic isoforms</p>
</li>
<li>Bcl-xL (long): anti-apoptotic, contains BH1-4 domains</li>
<li>Bcl-xS (short): pro-apoptotic, lacks BH1/BH2</li>
<li>Alternative 5' splice site selection in exon 2</li>
<li>
<p>Cancer relevance: Bcl-xL overexpression confers drug resistance</p>
</li>
<li>
<p><strong><a href="../../genes/human/VEGFA/VEGFA-ai-review.html">VEGFA</a></strong> - Differential matrix binding</p>
</li>
<li>VEGF121: freely diffusible, no heparin binding</li>
<li>VEGF165: intermediate, binds heparin, NRP1 coreceptor</li>
<li>VEGF189: matrix-bound, densest vessel sprouting</li>
<li>
<p>Different vascular patterning outcomes</p>
</li>
<li>
<p><strong><a href="../../genes/human/FAS/FAS-ai-review.html">FAS</a>/CD95</strong> - Membrane vs soluble antagonism</p>
</li>
<li>Membrane Fas: triggers apoptosis</li>
<li>Soluble Fas (lacks exon 6/TM domain): inhibits apoptosis</li>
<li>
<p>At least 7 isoforms identified</p>
</li>
<li>
<p><strong><a href="../../genes/human/FN1/FN1-ai-review.html">FN1</a> (Fibronectin)</strong> - Embryonic/wound healing specific</p>
</li>
<li>EDA/EDB (EIIIA/EIIIB) domains: alternative exons</li>
<li>Plasma FN: lacks both, soluble</li>
<li>Cellular FN: contains EDA/EDB, embryonic, wound healing</li>
<li>Double-null embryos have cardiovascular defects</li>
</ol>
<p><strong>Decision on <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a></strong>: Include with caveats - human <a href="../../genes/human/DSCAM/DSCAM-ai-review.html">DSCAM</a> does NOT have the 38,016 isoform diversity of <em>Drosophila</em> <a href="../../genes/DROME/Dscam1/Dscam1-ai-review.html">Dscam1</a>. The vertebrate equivalent is clustered protocadherins. Still worth reviewing but with lower priority.</p>
<p><strong>Next steps</strong>: Begin with <a href="../../genes/human/AGRN/AGRN-ai-review.html">AGRN</a> as it has clear, well-documented isoform-specific functions with clinical relevance.</p>
    </div>

    <footer>
        <small>Generated from ISOFORMS.md</small>
        <small>AI Gene Review Project</small>
    </footer>
</body>
</html>